What is the initial low dose of norepinephrine (vasopressor) for a patient weighing 45 kg with hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Low Dose of Norepinephrine for a 45 kg Patient with Hypotension

For a 45 kg patient with hypotension, the initial low dose of norepinephrine should be 0.1-0.5 mcg/kg/min, which translates to 4.5-22.5 mcg/min. 1, 2

Preparation and Administration

Dilution

  • Add 4 mg (4 mL) of norepinephrine to 1,000 mL of 5% dextrose solution
  • This creates a concentration of 4 mcg/mL 2
  • For a 45 kg patient:
    • At 0.1 mcg/kg/min: 4.5 mcg/min = approximately 1.1 mL/min (67 mL/hr)
    • At 0.5 mcg/kg/min: 22.5 mcg/min = approximately 5.6 mL/min (337 mL/hr)

Administration Route

  • Administer through a large vein, preferably via central venous catheter 2
  • If central access is unavailable, peripheral administration can be considered for short-term use (less than 24 hours) with careful monitoring for extravasation 1

Titration and Target

  • Initial observation period: Monitor response to initial dose for 2-3 minutes (8-12 mcg of base) 2
  • Target mean arterial pressure (MAP): 65 mmHg 3, 1
  • Adjust in increments of 0.05-0.2 mcg/kg/min every 10-15 minutes based on blood pressure response 1
  • For previously hypertensive patients, aim for a systolic blood pressure no higher than 40 mmHg below their baseline 2

Dosing Considerations for Weight

  • Weight-based dosing is appropriate for initial dosing in patients of all body sizes 4
  • Research shows that obese patients require lower weight-based doses but similar total doses compared to non-obese patients 4
  • The average maintenance dose typically ranges from 2-4 mcg/min (0.5-1 mL/min of the standard dilution) 2

Monitoring

  • Continuous cardiac monitoring is essential
  • Frequent blood pressure measurements
  • Regular assessment of tissue perfusion
  • Monitor for adverse effects:
    • Tachyarrhythmias
    • Increased myocardial oxygen consumption
    • Lactic acidosis
    • Hyperglycemia 1

Important Caveats

  • Always correct hypovolemia before or concurrently with norepinephrine administration 2, 5
  • Consider fluid bolus (5-10 mL/kg) if hypovolemia is suspected 1
  • In profound, life-threatening hypotension, earlier administration of norepinephrine simultaneously with fluid resuscitation may be beneficial 5
  • Avoid abrupt withdrawal; taper gradually when discontinuing 2
  • Low doses (<0.2 mcg/kg/min) are associated with lower mortality compared to intermediate (0.2-0.4 mcg/kg/min) or high doses (>0.4 mcg/kg/min) 6

Alternative Vasopressors

  • If norepinephrine is ineffective or contraindicated:
    • Epinephrine can be added or substituted 3
    • Vasopressin (0.03 units/minute) can be added to norepinephrine to raise MAP or decrease norepinephrine requirements 3
    • Dopamine may be considered only in selected patients with low risk of tachyarrhythmias 3, 1

References

Guideline

Management of Refractory Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Norepinephrine Dosing in Obese and Nonobese Patients With Septic Shock.

American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.